The Oncology Institute, Inc. (TOI)
USD 0.19
(-2.0%)
USD 0.19
(-2.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -70.45 Million USD | 19.27% |
| 2022 | 8.4 Million USD | -61.79% |
| 2021 | -7.93 Million USD | -267.34% |
| 2020 | -11.29 Million USD | -3776.03% |
| 2019 | 307.1 Thousand USD | -94.85% |
| 2018 | 9.07 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -14.84 Million USD | 9.56% |
| 2024 Q1 | -16.48 Million USD | 17.96% |
| 2023 Q1 | -13.38 Million USD | -0.83% |
| 2023 FY | - USD | 19.27% |
| 2023 Q4 | -13.7 Million USD | -19.97% |
| 2023 Q2 | -12.93 Million USD | 3.36% |
| 2023 Q3 | -11.42 Million USD | 11.64% |
| 2022 Q4 | -13.27 Million USD | 30.15% |
| 2022 Q3 | -18.99 Million USD | -10.52% |
| 2022 Q2 | -17.19 Million USD | 2.52% |
| 2022 Q1 | -17.63 Million USD | 55.9% |
| 2022 FY | - USD | -61.79% |
| 2021 Q1 | 100 Thousand USD | 100.71% |
| 2021 Q2 | -326.46 Thousand USD | -426.47% |
| 2021 Q4 | -39.99 Million USD | -3091.7% |
| 2021 Q3 | -1.25 Million USD | -283.8% |
| 2021 FY | - USD | -267.34% |
| 2020 Q3 | 2.08 Million USD | 6.19% |
| 2020 Q2 | 1.95 Million USD | 206.0% |
| 2020 Q1 | -1.84 Million USD | 0.0% |
| 2020 FY | - USD | -3776.03% |
| 2020 Q4 | -13.98 Million USD | -772.24% |
| 2019 FY | - USD | -94.85% |
| 2018 Q4 | -405.43 Thousand USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 137.255% |
| Addus HomeCare Corporation | 106.55 Million USD | 166.118% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | 348.849% |
| Amedisys, Inc. | 216.91 Million USD | 132.48% |
| American Oncology Network, Inc. | -39.35 Million USD | -79.04% |
| Astrana Health, Inc. | 123.68 Million USD | 156.961% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 258.866% |
| IMAC Holdings, Inc. | -5.94 Million USD | -1084.739% |
| biote Corp. | 9.23 Million USD | 862.985% |
| Cryo-Cell International, Inc. | -10.41 Million USD | -576.318% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 154.474% |
| COMPASS Pathways plc | -123.8 Million USD | 43.091% |
| DocGo Inc. | 32.72 Million USD | 315.29% |
| The Ensign Group, Inc. | 353.23 Million USD | 119.945% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 193.674% |
| InnovAge Holding Corp. | 1.15 Million USD | 6205.199% |
| Assure Holdings Corp. | -19.82 Million USD | -255.397% |
| The Joint Corp. | 9.14 Million USD | 870.686% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 32.854% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | -352.944% |
| ModivCare Inc. | -26.75 Million USD | -163.379% |
| NewGenIvf Group Limited | 384.3 Thousand USD | 18432.835% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | -1104.548% |
| Option Care Health, Inc. | 376.79 Million USD | 118.698% |
| P3 Health Partners Inc. | -81.07 Million USD | 13.096% |
| P3 Health Partners Inc. | -81.07 Million USD | 13.096% |
| The Pennant Group, Inc. | 30.36 Million USD | 331.993% |
| Surgery Partners, Inc. | 446.1 Million USD | 115.793% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | -2384.373% |
| Talkspace, Inc. | -22.01 Million USD | -220.056% |
| Talkspace, Inc. | -22.01 Million USD | -220.056% |
| The Oncology Institute, Inc. | -70.45 Million USD | -0.0% |